10 December 2018 - A medicine used to treat early stage breast cancer has been accepted by the SMC for use in NHSScotland.

Pertuzumab (Perjeta), which is used in combination with trastuzumab and chemotherapy to treat a particular type of breast cancer at an early stage and prior to surgery, was accepted following consideration through SMC’s PACE process, for medicines used at the end of life and for very rare conditions. 

Also accepted was nivolumab (Opdivo) for advanced melanoma.

Read SMC press release